134
Participants
Start Date
October 22, 2015
Primary Completion Date
December 22, 2016
Study Completion Date
December 6, 2018
burosumab
solution for SC injection
Placebo
saline solution for SC injection
St. Vincent's University Hospital, Dublin
Johns Hopkins University, Baltimore
Duke University Medical Center, Durham
The Ohio State University Wexner Medical Center, Columbus
Indiana University Department of Medicine, Indianapolis
Azienda Ospedaliero Universitaria Careggi - Neurofarba, Florence
Hôpital Lariboisière, Dept. of Rheumatology, Paris
CHU Paris Centre-Hôpital Cochin, Paris
Houston Methodist Hospital, Houston
Children's Hospital of Los Angeles, Los Angeles
University of California-San Francisco Medical Center, San Francisco
CHU de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre
Yale University School of Medicine, New Haven
Okayama Saiseikai General Hospital, Okayama
Osaka City University Hospital, Osaka
Osaka University Hospital, Osaka
Toranomon Hospital, Tokyo
The University of Tokyo Hospital, Tokyo
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
University of Edinburgh Edinburgh Clinical Trials Unit (ECTU) - Western General Hospital, Edinburgh
Univeristy College of London Hospital, London
University of Oxford, Oxford
Northern General Hospital, Metabolic Bone Centre (Sorby Wing), Sheffield
Royal National Orthopaedic Hospital, Stanmore
Lead Sponsor
Kyowa Kirin Co., Ltd.
INDUSTRY
Kyowa Kirin, Inc.
INDUSTRY